Phased Allocation of COVID-19 Vaccines: State and Territorial Approaches As of April 7, 2021 This table provides information on state and territorial plans for phased allocation of COVID-19 vaccines. As initial supply of COVID-19 vaccines is limited, Governors are focused on prioritizing certain high-risk populations for vaccine allocation through a transparent and equitable process. This table outlines state and territorial approaches according to Phases 1a-c, 2, and 3, however state Phases or Tiers may vary from this structure (e.g., additional phases or more condensed phasing) and such variations are noted where applicable for individual states. State planning for allocation to critical populations across Phases, including guidance for providers and the public, will continue to evolve and this document will be updated to reflect additional details as they are released. For additional information on allocation of COVID-19 vaccines, including federal recommendations and considerations for states, please see NGA’s Allocating COVID-19 Vaccines In Initial Phases Of Distribution: Federal Recommendations And Considerations For States. Given the robust and rapid nature of state efforts, the National Governors Association welcomes feedback on state actions that may be missing or have evolved since the release of this table. If there is information that should be added or amended, please contact Michelle LeBlanc
[email protected] or Brittney Roy
[email protected]. Phase 1a Phase 1b Phase 1c Phase 2 Phase 3 Alabama Frontline health workers, Persons age ≥75 years • Persons age 55-74 years All persons in age groups not including clinical and non-clinical, • People with intellectual and previously recommended for Vaccine in hospitals, nursing homes, or Essential workers at highest risk developmental disabilities vaccine, ages 16-64 and general Provider those providing in in-home or for work related exposure • Population defined as population not included in earlier Locator mental health care directly.